|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 496.50 USD | -0.39% |
|
-5.97% | +9.52% |
| 07-09 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 28.51x | 5.73x | 2.08x | 8.61x | 19.43x | 20.3x | -.--% | 126B | |
| 35.49x | 21.56x | 0.72x | 12.92x | 26.31x | 27.19x | 0.56% | 1,085B | |
| 27.65x | 6.95x | -1.84x | 6.35x | 17.24x | 19.06x | 2.06% | 624B | |
| 30.17x | 1346.43x | 0.12x | 7.39x | 15.12x | 15.55x | 2.74% | 442B | |
| 17.88x | 6.64x | 1.05x | 4.44x | 10.99x | 12.33x | 2.98% | 332B | |
| 22.38x | 5.23x | 1.01x | 4.7x | 13.12x | 14.02x | 1.86% | 277B | |
| 21.53x | 6.42x | -29.88x | 5.52x | 13.36x | 14.61x | 2.86% | 282B | |
| 14.08x | 6.2x | -11.33x | 5.27x | 10.83x | 12.68x | 3.55% | 217B | |
| 23.79x | 18.25x | 3.21x | 6.31x | 11.13x | 14.44x | 2.77% | 196B | |
| -47.8x | 8.43x | 0.34x | 5.8x | 32.25x | 64.08x | 2.41% | 167B | |
| 12.27x | 1.57x | 0.27x | 3.04x | 7.56x | 8.66x | 7.22% | 138B | |
| 11.5x | 5.09x | 0.25x | 3.11x | 8.3x | 9.03x | 4.34% | 118B | |
| 12.48x | 4.52x | 1.11x | 2.76x | 8.07x | 9.13x | 3.56% | 105B | |
| 11.54x | 1.22x | 3.26x | 2.15x | 6.93x | 7.9x | 5.56% | 105B | |
| 23.81x | 5.39x | 1.39x | 8.07x | 15.26x | 15.96x | 1.86% | 74.59B | |
| 21.85x | 1.78x | -0.13x | 1.79x | 8.48x | 14.25x | 0.45% | 56.94B | |
| 43.89x | 1.16x | 53.65x | 2.68x | 9.86x | 27.3x | 3.79% | 52.53B | |
| 39.59x | 5.36x | 2.08x | 8.95x | 29.81x | 30.71x | 0.48% | 54B | |
| 41.34x | 19.64x | 0.18x | 6.93x | 31.52x | 30.63x | -.--% | 41.76B | |
| 18.6x | 1.87x | 3.97x | 3.39x | 12.73x | 14.29x | 2.22% | 42.54B | |
| Average | 20.53x | 73.97x | 1.58x | 5.51x | 15.42x | 19.11x | 2.56% | 226.82B | |
| Weighted average by Cap. | 23.40x | 140.63x | -1.30x | 7.29x | 17.33x | 19.90x | 2.22% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector valuations
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
